Related Experiment Videos
[Analysis of 30 patients with hypercalcemia]
T Kobayashi1, M Baba, N Tanaka
1Department of Surgery II, Osaka University Medicine School, Japan.
Nihon Geka Gakkai Zasshi
|October 1, 1993
Summary
Hypercalcemia diagnosis requires vigilance for vague symptoms. High parathyroid hormone (PTH) levels can indicate primary hyperparathyroidism or malignancy, necessitating further evaluation for conditions like Multiple Endocrine Neoplasia type 1 (MEN 1).
Area of Science:
- Endocrinology
- Oncology
- Medical Diagnostics
Context:
- Hypercalcemia, characterized by elevated serum calcium, presents with non-specific symptoms, complicating diagnosis.
- The study retrospectively analyzed 30 hypercalcemia cases treated between 1984 and 1991.
- Etiologies included primary hyperparathyroidism (n=24) and malignancy (n=6).
Purpose:
- To investigate the diagnostic challenges and clinical features of hypercalcemia.
- To differentiate between hypercalcemia causes, particularly primary hyperparathyroidism and malignancy.
- To identify specific indicators for conditions like Multiple Endocrine Neoplasia type 1 (MEN 1).
Summary:
- Hypercalcemia lacks specific symptoms, emphasizing its consideration in patients with general complaints.
- Malignancy-associated hypercalcemia typically presents with elevated serum calcium and parathyroid hormone (PTH) levels.
- Severely elevated PTH (>2000 pg/mL) in primary hyperparathyroidism suggests multiple gland hyperplasia and warrants MEN 1 evaluation.
Impact:
- Highlights the importance of considering hypercalcemia in differential diagnoses for unexplained symptoms.
- Provides insights into distinguishing malignancy-related hypercalcemia based on serum calcium and PTH levels.
- Underscores the utility of high-sensitivity PTH assays in identifying potential MEN 1 cases requiring specific diagnostic and surgical approaches.